BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37803338)

  • 21. Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Hu N; Fan XP; Fan YC; Chen LY; Qiao CY; Han LY; Wang K
    Tohoku J Exp Med; 2017 Jun; 242(2):93-100. PubMed ID: 28592717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of circulating cell-free DNA in diagnosis of hepatocelluar carcinoma.
    Chen K; Zhang H; Zhang LN; Ju SQ; Qi J; Huang DF; Li F; Wei Q; Zhang J
    World J Gastroenterol; 2013 May; 19(20):3143-9. PubMed ID: 23716996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-Fetoprotein Detection of Hepatocellular Carcinoma Leads to a Standardized Analysis of Dynamic AFP to Improve Screening Based Detection.
    Bird TG; Dimitropoulou P; Turner RM; Jenks SJ; Cusack P; Hey S; Blunsum A; Kelly S; Sturgeon C; Hayes PC; Bird SM
    PLoS One; 2016; 11(6):e0156801. PubMed ID: 27308823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
    Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Cell-Free DNA and DNA Integrity as Molecular Diagnostic Tools in Hepatocellular Carcinoma.
    Elzehery R; Effat N; El Farahaty R; Elsayed Farag R; Abo-Hashem EM; Elhelaly R
    Am J Clin Pathol; 2022 Aug; 158(2):254-262. PubMed ID: 35403666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of DNA methylation signatures for hepatocellular carcinoma detection and microvascular invasion prediction.
    Hao Y; Yang Q; He Q; Hu H; Weng Z; Su Z; Chen S; Peng S; Kuang M; Chen Z; Xu L
    Eur J Med Res; 2022 Dec; 27(1):276. PubMed ID: 36464701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developments and current status of cell-free DNA in the early detection and management of hepatocellular carcinoma.
    Du S; Cao K; Yan Y; Wang Y; Wang Z; Lin D
    J Gastroenterol Hepatol; 2024 Feb; 39(2):231-244. PubMed ID: 37990622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
    Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
    Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma.
    Oussalah A; Rischer S; Bensenane M; Conroy G; Filhine-Tresarrieu P; Debard R; Forest-Tramoy D; Josse T; Reinicke D; Garcia M; Luc A; Baumann C; Ayav A; Laurent V; Hollenbach M; Ripoll C; Guéant-Rodriguez RM; Namour F; Zipprich A; Fleischhacker M; Bronowicki JP; Guéant JL
    EBioMedicine; 2018 Apr; 30():138-147. PubMed ID: 29627389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypermethylation of secreted frizzled related protein 2 gene promoter serves as a noninvasive biomarker for HBV-associated hepatocellular carcinoma.
    Xiang L; Chen LM; Zhai YJ; Sun WJ; Yang JR; Fan YC; Wang K
    Life Sci; 2021 Apr; 270():119061. PubMed ID: 33454364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma.
    Jain S; Chen S; Chang KC; Lin YJ; Hu CT; Boldbaatar B; Hamilton JP; Lin SY; Chang TT; Chen SH; Song W; Meltzer SJ; Block TM; Su YH
    PLoS One; 2012; 7(4):e35789. PubMed ID: 22536438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients.
    Choy LYL; Peng W; Jiang P; Cheng SH; Yu SCY; Shang H; Olivia Tse OY; Wong J; Wong VWS; Wong GLH; Lam WKJ; Chan SL; Chiu RWK; Chan KCA; Lo YMD
    Clin Chem; 2022 Sep; 68(9):1151-1163. PubMed ID: 35587130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?
    Jeepalyam S; Sheel A; Ejaz A; Miller E; Manne A
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762533
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Li B; Huang H; Huang R; Zhang W; Zhou G; Wu Z; Lv C; Han X; Jiang L; Li Y; Li B; Zhang Z
    Dis Markers; 2020; 2020():6289063. PubMed ID: 33178361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
    Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X
    Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RASSF1A and SOCS1 genes methylation status as a noninvasive marker for hepatocellular carcinoma.
    Pasha HF; Mohamed RH; Radwan MI
    Cancer Biomark; 2019; 24(2):241-247. PubMed ID: 30689554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma.
    Liu HH; Fang Y; Wang JW; Yuan XD; Fan YC; Gao S; Han LY; Wang K
    Medicine (Baltimore); 2020 May; 99(20):e20326. PubMed ID: 32443384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study.
    Lu SX; Huang YH; Liu LL; Zhang CZ; Yang X; Yang YZ; Shao CK; Li JM; Xie D; Zhang X; Jain D; Yun JP
    Br J Cancer; 2021 Jun; 124(12):1988-1996. PubMed ID: 33824478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Diagnostic Value of Serum PIVKA-II Alone or in Combination with AFP in Chinese Hepatocellular Carcinoma Patients.
    Xu F; Zhang L; He W; Song D; Ji X; Shao J
    Dis Markers; 2021; 2021():8868370. PubMed ID: 33628341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].
    Wang XJ; Shen RF; Wang X; Wang YR; Xiao T
    Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.